CAMLINFINE103.71

Camlin Fine Sciences Limited

· Chemicals
AnnualQuarterly₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,992 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations405.9385.9401.7395.9423.0433.5437.5423.6459.8457.2424.8519.9
Other Income1.81.75.81.912.11.39.68.64.62.923.91.3
Total Income407.6387.6407.5397.7435.1434.8447.1432.1464.4460.1448.7521.2
Expenses
+ Cost of Materials Consumed206.2156.2136.7214.5223.1173.3194.9225.9209.0267.7120.7312.3
+ Purchases of Stock-in-Trade12.339.043.315.853.945.42.417.431.913.718.25.8
+ Changes in Inventories5.217.481.6-12.4-57.9-2.318.1-6.45.8-33.479.9-12.5
+ Employee Benefit Expense43.245.546.251.252.352.050.159.660.363.865.973.4
+ Finance Costs19.814.116.223.426.434.116.115.818.918.323.014.0
+ Depreciation & Amortisation19.220.620.020.120.714.518.416.918.816.720.819.2
+ Other Expenses113.9104.5107.1108.5108.4116.4112.6108.1119.4123.4118.9131.5
Total Expenses419.7397.3451.2421.2426.8433.3412.6437.3464.1470.2447.4543.8
EBITDA25.123.3-13.318.143.248.859.419.033.422.021.29.3
EBIT5.92.7-33.3-2.022.634.341.02.114.65.30.4-9.9
Profit
PBT before Exceptional Items-12.1-9.7-43.7-23.58.21.534.5-5.20.3-10.11.3-22.5
+ Exceptional Items0.00.0-49.80.0-151.00.0-5.60.00.0-17.5-7.9-11.1
Pretax Income-12.1-9.7-93.5-23.5-142.81.528.9-5.20.3-27.6-6.6-33.7
+ Current Tax7.96.56.57.416.44.314.06.05.64.41.93.9
+ Deferred Tax0.9-1.9-18.23.8-42.62.8-6.0-6.00.3-4.4-8.2-4.3
Tax Expense8.74.5-11.711.2-26.27.18.0-0.05.90.0-6.2-0.5
+ Share of Associates & JVs0.00.00.00.00.5-1.81.80.9-0.4-0.31.41.4
Net Income-20.8-14.3-81.8-34.7-116.1-7.50.1-10.7-15.0-37.186.3-33.6
+ Net Income — Continuing Ops-20.8-14.3-81.8-34.7-116.6-5.621.0-5.1-5.6-27.6-0.4-33.2
+ Net Income — Discontinued Ops0.00.00.00.00.00.0-22.6-6.4-8.9-9.285.3-1.8
+ Other Comprehensive Income-2.516.4-0.9-5.90.0-12.15.811.9-1.04.4-11.917.3
Total Comprehensive Income-23.32.1-82.7-40.6-116.1-19.65.91.2-15.9-32.774.4-16.4
Net Income to Common-19.4-11.8-77.1-34.0-100.2-4.1-0.7-10.0-14.4-36.288.2-31.7
Minority Interest-1.4-2.5-4.6-0.7-15.9-3.30.8-0.7-0.6-0.9-1.9-1.9
Per Share
Basic EPS-1.17-0.71-4.64-2.03-5.98-0.24-0.04-0.53-0.76-1.914.59-1.65
Diluted EPS-1.16-0.70-4.58-2.01-5.93-0.24-0.04-0.52-0.76-1.914.54-1.65
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.00.00.00.00.0-22.6-6.4-8.9-9.285.5-1.8
+ Tax — Discontinued Operations0.00.00.00.00.00.00.00.00.00.00.20.0
Other Comprehensive Income — detail
+ Other Comprehensive Income5.811.9-1.04.4-11.917.3
+ Items NOT to be Reclassified to P&L-0.00.1-0.0-0.2-0.20.10.20.2-1.20.20.7-0.1
+ Tax on Items NOT to be Reclassified0.10.1-0.40.10.2-0.0
+ Tax on Items NOT to be Reclassified — alt tag-0.00.0-0.0-0.1-0.10.0
+ Items to be Reclassified to P&L-3.116.3-1.0-5.5-0.1-13.46.611.9-2.14.4-13.119.3
+ Tax on Items to be Reclassified1.00.1-1.90.1-0.82.0
+ Tax on Items to be Reclassified — alt tag-0.6-0.0-0.10.4-0.3-1.3
Comprehensive Income — Owners of Parent-2.516.2-0.8-6.50.2-15.34.41.9-14.5-31.378.6-14.0
Comprehensive Income — Non-controlling Interests0.00.2-0.10.5-0.2-4.31.5-0.7-1.4-1.4-4.2-2.4
Per Share — as-filed variants
Basic EPS — Continuing Operations-1.17-0.71-4.64-2.03-5.98-0.241.17-0.22-0.31-1.440.35-1.60
Diluted EPS — Continuing Operations-1.16-0.70-4.58-2.01-5.93-0.241.16-0.21-0.31-1.440.35-1.60
Basic EPS — Discontinued Operations0.000.000.000.000.000.00-1.21-0.31-0.45-0.474.24-0.05
Diluted EPS — Discontinued Operations0.000.000.000.000.000.00-1.20-0.31-0.45-0.474.19-0.05
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit182.3173.3140.1177.8203.9217.2222.2186.7213.1209.2206.0214.2
Gross Margin %44.9144.9134.8744.9248.2150.1050.7844.0746.3545.7548.5041.20
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-12.1-9.7-43.7-23.58.21.534.5-5.20.3-10.11.3-22.5
− Exceptional Items (reconciliation)0.00.0-49.80.0-151.00.0-5.60.00.0-17.5-7.9-11.1
Net Income Adj (tax-effected)-20.8-14.3-38.2-34.77.2-7.54.2-10.7-15.0-19.689.5-22.7
EPS Adj-1.17-0.71-2.17-2.030.37-0.24-1.51-0.53-0.76-1.014.76-1.11
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.001.001.001.001.001.001.001.001.00
Filed Debt Equity0.000.000.000.000.72
Filed Dscr0.000.000.000.000.01
Paid Up Equity Capital16.716.716.716.716.716.718.818.818.819.219.219.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.